Black Rock Inc. Halozyme Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 17,619,937 shares of HALO stock, worth $1.05 Billion. This represents 0.02% of its overall portfolio holdings.

Number of Shares

17,619,937

Previous 18,241,548 3.41%

Holding current value

$1.05 Billion

Previous $742 Million 24.33%

% of portfolio

0.02%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$37.81 - $52.4 $23.5 Million - $32.6 Million	-621,611 Reduced 3.41%	17,619,937 $923 Million
Q1 2024 May 10, 2024	SELL	$33.68 - $41.95 $13.1 Million - $16.3 Million	-389,415 Reduced 2.09%	18,241,548 $742 Million
Q4 2023 Feb 13, 2024	BUY	$33.32 - $42.1 $17.1 Million - $21.6 Million	512,348 Added 2.83%	18,630,963 $689 Million
Q3 2023 Nov 13, 2023	SELL	$36.46 - $44.03 $17.7 Million - $21.4 Million	-485,878 Reduced 2.61%	18,118,615 $692 Million
Q2 2023 Aug 11, 2023	BUY	$30.28 - $38.74 $13.9 Million - $17.8 Million	458,641 Added 2.53%	18,604,493 $671 Million
Q1 2023 May 12, 2023	SELL	$32.86 - $55.7 $2.3 Million - $3.89 Million	-69,874 Reduced 0.38%	18,145,852 $693 Million
Q4 2022 Feb 13, 2023	BUY	$40.06 - $59.44 $644,685 - $956,567	16,093 Added 0.09%	18,215,726 $1.04 Billion
Q3 2022 Nov 14, 2022	SELL	$38.53 - $51.78 $7 Million - $9.41 Million	-181,772 Reduced 0.99%	18,199,633 $720 Million
Q2 2022 Aug 12, 2022	SELL	$37.35 - $48.3 $48.1 Million - $62.3 Million	-1,288,820 Reduced 6.55%	18,381,405 $809 Million
Q1 2022 May 12, 2022	BUY	$31.97 - $41.06 $7.36 Million - $9.46 Million	230,362 Added 1.18%	19,670,225 $784 Million
Q4 2021 Feb 10, 2022	BUY	$31.82 - $40.75 $4.6 Million - $5.89 Million	144,483 Added 0.75%	19,439,863 $782 Million
Q3 2021 Nov 09, 2021	BUY	$38.47 - $46.42 $8.81 Million - $10.6 Million	228,942 Added 1.2%	19,295,380 $785 Million
Q2 2021 Aug 11, 2021	BUY	$38.84 - $51.31 $741 Million - $978 Million	19,066,438 New	19,066,438 $866 Million

Others Institutions Holding HALO

# of Institutions

488

Shares Held

122M

Call Options Held

208K

Put Options Held

66.3K

View Full List

About HALOZYME THERAPEUTICS, INC.

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $8.29B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

More about HALO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account